Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Over 1 million shares traded today

<< Previous

Bullboard Posts

Next >>

Comment by scarlet1967on Jan 19, 2021 4:13pm

109 Views

Post# 32329015

RE:RE:RE:RE:Over 1 million shares traded today

I am more thinking about our old friends shorting cause the knew the outcome.

palinc2000 wrote: I dont think there were short sells because the the Shares were issued today so no need to short

scarlet1967 wrote: Love to know how many of those were short sells.

palinc2000 wrote: 1.3 MILLION shares traded ,,,,Most sales from those who acquired the Units ......

palinc2000 wrote: Exactly as I predicted ,,,,the new Holders are selling the stock and keeping the warrant,
Congratulations to Dubuc ......